Strengthening Medical Ethics: Addressing Over-Treatment and Improving Clinical Transparency

South Korean health authorities are intensifying oversight of medical practices to curb unnecessary procedures and improve patient trust in the clinical environment. The Ministry of Health and Welfare (MOHW) has announced a series of policy adjustments aimed at identifying “ghost surgeries” and excessive diagnostic testing, which have historically undermined the doctor-patient relationship. These measures include stricter monitoring of billing codes and enhanced requirements for informed consent, as reported by the Ministry of Health and Welfare.

Why Are Medical Authorities Cracking Down on Over-Treatment?

The primary driver for these policy shifts is a persistent rise in healthcare expenditures tied to non-essential treatments. According to the Health Insurance Review and Assessment Service (HIRA), clinical data analysis reveals a significant variance in the frequency of specific injections and imaging tests among similar patient demographics.

Regulatory bodies argue that when medical decisions prioritize profit over clinical necessity, it erodes the foundation of public health. By standardizing “appropriate care” criteria, HIRA intends to flag institutions that deviate significantly from established clinical guidelines. This move is designed to ensure that patients receive treatment based on medical necessity rather than financial quotas.

What Are the New Measures for Clinical Accountability?

To increase transparency, the government is implementing a more rigorous audit process for medical institutions. The following strategies are now being prioritized:

• Data-Driven Audits: HIRA is utilizing artificial intelligence to detect “outlier” clinics that consistently perform high volumes of elective procedures or diagnostic tests that lack clear diagnostic justification.
• Stricter Informed Consent: New regulations require physicians to provide detailed explanations of why a specific test or procedure is necessary, including a breakdown of potential risks and alternatives.
• Public Reporting: The government plans to publish more granular data regarding hospital performance, allowing patients to compare the quality and necessity of care across different providers.

These actions mirror international trends, such as the “Choosing Wisely” campaign led by the ABIM Foundation, which encourages clinicians to avoid low-value care that offers little benefit to the patient.

How Do These Policies Affect Patient Care?

The shift in policy aims to empower patients to ask more questions during consultations. When a provider suggests an expensive or invasive procedure, patients are encouraged to request the clinical reasoning behind the recommendation.

Key Takeaways for Patients

• Ask for Alternatives: Always inquire if there are less invasive or lower-cost options that provide similar diagnostic value.
• Verify Necessity: If a test is recommended, ask how the results will directly change the treatment plan.
• Seek Second Opinions: For major elective procedures, consulting with a secondary specialist can provide clarity on whether the intervention is truly indicated.

Future Outlook: Improving the Clinical Environment

The long-term goal of these regulatory changes is to move away from a fee-for-service model that rewards volume and toward a value-based care system. By aligning financial incentives with patient health outcomes, the government hopes to restore the integrity of the medical profession. While these changes may create friction in the short term for some providers, the focus remains on ensuring that medical treatment is driven by evidence-based medicine rather than commercial interest. As the Ministry of Health and Welfare continues to refine these oversight protocols, the clinical landscape is expected to prioritize outcomes and patient safety over procedural frequency.